INTRODUCTION: Plasmodium vivax malaria affects billions of people annually. This study aimed to note the presentations and complications and subsequently to identify the determinants of in-patient hospital care of P. vivax malaria patients presenting to a tertiary care hospital in Karachi, Pakistan. Severity of the shock was also assessed using a shock index. METHODOLOGY: This study descriptive cross-sectional study was conducted at the Emergency Department of Aga Khan University Hospital, Karachi. All adult patients with a positive P. vivax peripheral film and/or immunochromatography admitted through the department were studied during 2009. Data was entered and analyzed using SPSS version 16. Keeping the length of stay at a cut-off of 48 ...
To compare the severity of Plasmodium vivax malaria with that of P. falciparum malaria, we conducted...
Background: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Context: Plasmodium vivax is geographically widely distributed with up to 2.5 billion people at risk...
INTRODUCTION: Plasmodium vivax malaria affects billions of people annually. This study aimed to note...
INTRODUCTION: Plasmodium vivax malaria affects billions of people annually. This study aimed to note...
INTRODUCTION: Plasmodium vivax malaria affects billions of people annually. This study aimed to note...
INTRODUCTION: Plasmodium vivax malaria affects billions of people annually. This study aimed to note...
Background: Malaria is an important cause of mortality and morbidity in India. Many recent studies h...
Background: Malaria remains an endemic disease in Pakistan with an estimated healthcare burden of 1....
Background: Malaria remains an endemic disease in Pakistan with an estimated healthcare burden of 1....
Background Malaria remains an endemic disease in Pakistan with an estimated healthcare burden of 1.6...
Background: Traditionally Plasmodium falciparum has been considered to cause severe malaria while Pl...
BACKGROUND: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Objectives Despite declining malaria cases, it remains a public health concern in our country, pro...
BACKGROUND: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
To compare the severity of Plasmodium vivax malaria with that of P. falciparum malaria, we conducted...
Background: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Context: Plasmodium vivax is geographically widely distributed with up to 2.5 billion people at risk...
INTRODUCTION: Plasmodium vivax malaria affects billions of people annually. This study aimed to note...
INTRODUCTION: Plasmodium vivax malaria affects billions of people annually. This study aimed to note...
INTRODUCTION: Plasmodium vivax malaria affects billions of people annually. This study aimed to note...
INTRODUCTION: Plasmodium vivax malaria affects billions of people annually. This study aimed to note...
Background: Malaria is an important cause of mortality and morbidity in India. Many recent studies h...
Background: Malaria remains an endemic disease in Pakistan with an estimated healthcare burden of 1....
Background: Malaria remains an endemic disease in Pakistan with an estimated healthcare burden of 1....
Background Malaria remains an endemic disease in Pakistan with an estimated healthcare burden of 1.6...
Background: Traditionally Plasmodium falciparum has been considered to cause severe malaria while Pl...
BACKGROUND: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Objectives Despite declining malaria cases, it remains a public health concern in our country, pro...
BACKGROUND: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
To compare the severity of Plasmodium vivax malaria with that of P. falciparum malaria, we conducted...
Background: Infection by Plasmodium vivax has been considered rarely threatening to life, but recent...
Context: Plasmodium vivax is geographically widely distributed with up to 2.5 billion people at risk...